Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model

26Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives. The main goal of this work was to analyse how treatment intervention with tofacitinib prevents the early disturbances of bone structure and mechanics in the rat model of adjuvant-induced arthritis. This is the first study to access the impact of tofacitinib on the skeletal bone effects of inflammation. Methods. Fifty Wistar rats with adjuvant-induced arthritis were randomly housed in experimental groups, as follows: non-arthritic healthy group (n = 20); arthritic non-treated group (n = 20); and 10 animals undergoing tofacitinib treatment. Rats were monitored during 22 days after disease induction for the inflammatory score, ankle perimeter and body weight. Healthy non-arthritic rats were used as controls for comparison. After 22 days of disease progression, rats were killed and bone samples collected for histology, micro-CT, three-point bending and nanoindentation analysis. Blood samples were also collected for quantification of bone turnover markers and systemic cytokines. Results. At the tissue level, measured by nanoindentation, tofacitinib increased bone cortical and trabecular hardness. However, micro-CT and three-point bending tests revealed that tofacitinib did not reverse the effects of arthritis on the cortical and trabecular bone structure and on mechanical properties. Conclusion. Possible reasons for these observations might be related to the mechanism of action of tofacitinib, which leads to direct interactions with bone metabolism, and/or to the kinetics of its bone effects, which might need longer exposure.

References Powered by Scopus

G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences

44811Citations
N/AReaders
Get full text

Osteoclast differentiation and activation

5560Citations
N/AReaders
Get full text

Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee

5019Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Cytokine networks in the pathogenesis of rheumatoid arthritis

281Citations
N/AReaders
Get full text

Pharmacological Management of Osteoporosis in Rheumatoid Arthritis Patients: A Review of the Literature and Practical Guide

71Citations
N/AReaders
Get full text

Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments

68Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Vidal, B., Cascao, R., Finnila, M. A. J., Lopes, I. P., Da Gloria, V. G., Saarakkala, S., … Fonseca, J. E. (2018). Effects of tofacitinib in early arthritis-induced bone loss in an adjuvant-induced arthritis rat model. Rheumatology (United Kingdom), 57(8), 1461–1471. https://doi.org/10.1093/rheumatology/kex258

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

53%

Researcher 6

40%

Lecturer / Post doc 1

7%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

50%

Engineering 2

20%

Biochemistry, Genetics and Molecular Bi... 2

20%

Design 1

10%

Save time finding and organizing research with Mendeley

Sign up for free